MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy

被引：0
|
作者：
Jin Jin
Tianjiao Liu
Jiali Cheng
Jiao Meng
Na Wang
Liang Huang
Xiaoxi Zhou
Liting Chen
Hui Luo
Jianfeng Zhou
机构：
[1] Huazhong University of Science and Technology,Department of Hematology, Tongji Hospital, Tongji Medical College
[2] Cancer Hospital of Harbin Medical University,Department of Hematology
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
Chimeric antigen receptor-T therapy; Relapse; Cytokines; Biomarkers; MIP3α; T-cell infiltration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2245 / 2256
页数：11
相关论文
共 50 条
  • [1] MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy
    Jin, Jin
    Liu, Tianjiao
    Cheng, Jiali
    Meng, Jiao
    Wang, Na
    Huang, Liang
    Zhou, Xiaoxi
    Chen, Liting
    Luo, Hui
    Zhou, Jianfeng
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (07) : 2245 - 2256
  • [2] MIP3α As an Early Prognostic Predictor for Patients with B-Cell Malignancies Receiving CD19/CD22-Redirected CAR T-Cell Cocktail Therapy
    Jin, Jin
    Cheng, Jiali
    Wang, Na
    Huang, Liang
    Zhou, Xiaoxi
    Chen, Liting
    Luo, Hui
    Liu, Tianjiao
    Meng, Jiao
    BLOOD, 2022, 140 : 10265 - 10266
  • [3] CD19/CD22 CAR-T Cell Cocktail Therapy Following Autologous Transplantation in Patients with Relapsed/Refractory B-Cell Lymphomas
    Cao, Yang
    Xiao, Yi
    Wang, Na
    Wang, Gaoxiang
    Zhou, Xiaoxi
    Huang, Liang
    Chen, Liting
    Xiao, Min
    Zhang, Tongcun
    Zhang, Yicheng
    Zhou, Jianfeng
    BLOOD, 2020, 136
  • [4] Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies
    Pu, Lian-Fang
    Zheng, Hui-Min
    Feng, Xiang-Jiang
    Charwudzi, Alice
    Liang, Xue
    Hu, Lin-Hui
    Ding, Yang-Yang
    Liu, Ze-Lin
    Liao, Ya
    Xiong, Shu-Dao
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [5] Enhanced efficacy of CD19/CD22 bispecific CAR-T cells with EAAAK linker on B-cell malignancies
    Ma, Renyuxue
    You, Fengtao
    Tian, Shuaiyu
    Zhang, Tingting
    Tian, Xiaopeng
    Xiang, Shufen
    Wu, Hai
    Yang, Nan
    An, Gangli
    Yang, Lin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 64 - 74
  • [6] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China(Life Sciences), 2023, 66 (04) : 754 - 770
  • [7] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China(Life Sciences) , 2023, (04) : 754 - 770
  • [8] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Chen, Zhaoqi
    Liu, Yan
    Chen, Nianci
    Xing, Haiyan
    Tian, Zheng
    Tang, Kejing
    Rao, Qing
    Xu, Yingxi
    Wang, Ying
    Wang, Min
    Wang, Jianxiang
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (04) : 754 - 770
  • [9] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China Life Sciences, 2023, 66 : 754 - 770
  • [10] Genomic Drivers of Large B-Cell Lymphoma Resistance to CD19 CAR-T Therapy
    Jain, Michael D.
    Ziccheddu, Bachisio
    Coughlin, Caroline A.
    Faramand, Rawan
    Griswold, Anthony J.
    Reid, Kayla M.
    Landgren, Ola
    Locke, Frederick L.
    Maura, Francesco
    Davila, Marco L.
    Schatz, Jonathan H.
    BLOOD, 2021, 138
12345